Fujita Masayo

Mouse Model of Parkinson's Disease with Bilateral Dorsal Striatum Lesion with 6-Hydroxydopamine Exhibits Cognitive Apathy-like Behavior.

Masato Okitsu, Masayo Fujita, Yuki Moriya, Hiroko Kotajima-Murakami, Soichiro Ide, Rika Kojima, Kazunari Sekiyama, Kazushi Takahashi, Kazutaka Ikeda

International journal of molecular sciences, 25(14), Jul 22, 2024

Involvement of muscarinic receptors in psychomotor hyperactivity in dopamine-deficient mice

Masayo Fujita, Yukiko Ochiai, Yoko Hagino, Kazuto Kobayashi, Geoffrey Pavey, Brian Dean, Kazutaka Ikeda

Molecular Brain, 15(1), Nov 29, 2022 Peer-reviewed

Therapeutic Effects of Quetiapine and 5-HT1A Receptor Agonism on Hyperactivity in Dopamine-Deficient Mice

Yukiko Ochiai, Masayo Fujita, Yoko Hagino, Kazuto Kobayashi, Ryoichi Okiyama, Kazushi Takahashi, Kazutaka Ikeda

International Journal of Molecular Sciences, 23(13) 7436-7436, Jul 4, 2022 Peer-reviewed

Impaired wakefulness and rapid eye movement sleep in dopamine-deficient mice.

Mitsuaki Kashiwagi, Mika Kanuka, Kaeko Tanaka, Masayo Fujita, Ayaka Nakai, Chika Tatsuzawa, Kazuto Kobayashi, Kazutaka Ikeda, Yu Hayashi

Molecular brain, 14(1) 170-170, Nov 18, 2021 Peer-reviewed

Correction to: Increase in excitability of hippocampal neurons during novelty-induced hyperlocomotion in dopamine-deficient mice.

Masayo Fujita, Yukiko Ochiai, Taishi-Clark Takeda, Yoko Hagino, Kazuto Kobayashi, Kazutaka Ikeda

Molecular brain, 14(1) 51-51, Mar 11, 2021

Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease.

Jianshe Wei, Yoshiki Takamatsu, Ryoko Wada, Masayo Fujita, Gilbert Ho, Eliezer Masliah, Makoto Hashimoto

Biomolecules, 11(2), Feb 15, 2021

Increase in excitability of hippocampal neurons during novelty-induced hyperlocomotion in dopamine-deficient mice.

Masayo Fujita, Yukiko Ochiai, Taishi-Clark Takeda, Yoko Hagino, Kazuto Kobayashi, Kazutaka Ikeda

Molecular brain, 13(1) 126-126, Sep 18, 2020

Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.

Masayo Fujita, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Kazutaka Ikeda, Makoto Hashimoto

International journal of molecular sciences, 21(8), Apr 19, 2020

Opioid and nondopamine reward circuitry and state-dependent mechanisms.

Masayo Fujita, Soichiro Ide, Kazutaka Ikeda

Annals of the New York Academy of Sciences, 1451(1) 29-41, Sep, 2019 Peer-reviewed

Current and future clinical utilities of Parkinson's Disease and dementia biomarkers: can they help us conquer the disease?

Ho G, Takamatsu Y, Waragai M, Wada R, Sugama S, Takenouchi T, Fujita M, Ali A, Hsieh MH, Hashimoto M

Expert review of neurotherapeutics, 19(11) 1149-1161, Jul, 2019 Peer-reviewed

Immature-like molecular expression patterns in the hippocampus of a mouse model of dementia with Lewy body-linked mutant β-synuclein.

Hideo Hagihara, Masayo Fujita, Juzoh Umemori, Makoto Hashimoto, Tsuyoshi Miyakawa

Molecular brain, 11(1) 38-38, Jul 6, 2018 Peer-reviewed

Early manifestation of depressive-like behavior in transgenic mice that express dementia with Lewy body-linked mutant β-synuclein.

Masayo Fujita, Yoko Hagino, Yukio Takamatsu, Yuka Shimizu, Yoshiki Takamatsu, Kazutaka Ikeda, Makoto Hashimoto

Neuropsychopharmacology reports, 38(2) 95-97, Jun, 2018 Peer-reviewed

Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability?

Yoshiki Takamatsu, Masayo Fujita, Gilbert J Ho, Ryoko Wada, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Eliezer Masliah, Makoto Hashimoto

Parkinson's disease, 2018 5789424-5789424, 2018 Peer-reviewed

Light/dark phase-dependent spontaneous activity is maintained in dopamine-deficient mice.

Masayo Fujita, Yoko Hagino, Taishi Takeda, Shinya Kasai, Miho Tanaka, Yukio Takamatsu, Kazuto Kobayashi, Kazutaka Ikeda

Molecular brain, 10(1) 49-49, Oct 16, 2017 Peer-reviewed

Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.

Yoko Hagino, Shinya Kasai, Masayo Fujita, Susumu Setogawa, Hiroshi Yamaura, Dai Yanagihara, Makoto Hashimoto, Kazuto Kobayashi, Herbert Y Meltzer, Kazutaka Ikeda

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(5) 1141-50, Mar 13, 2015 Peer-reviewed

Role of Autophagy in P2X7 Receptor-Mediated Maturation and Unconventional Secretion of IL-1β in Microglia

Takato Takenouchi, Kazunari Sekiyama, Mitsutoshi Tsukimoto, Yoshifumi Iwamaru, Masayo Fujita, Shuei Sugama, Hiroshi Kitani, Makoto Hashimoto

Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging, 6 211-222, Jan 5, 2015 Peer-reviewed

Disease modifying effect of adiponectin in model of alpha-synucleinopathies

Kazunari Sekiyama, Masaaki Waragai, Hiroyasu Akatsu, Shuei Sugama, Takato Takenouchi, Yoshiki Takamatsu, Masayo Fujita, Akio Sekigawa, Edward Rockenstein, Satoshi Inoue …

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 1(7) 479-489, Jul, 2014 Peer-reviewed

Dual effects of β-synuclein on the pathogenesis of Parkinson disease.

Akio Sekigawa, Kazunari Sekiyama, Masayo Fujita, Yoshiki Takamatsu, Albert R La Spada, Eliezer Masliah, Makoto Hashimoto

Annals of neurology, 74(2) 306-306, Aug, 2013 Peer-reviewed

Corticosteroids limit microglial activation occurring during acute stress.

Sugama S, Takenouchi T, Fujita M, Kitani H, Conti B, Hashimoto M

Neuroscience, 232 13-20, Mar, 2013 Peer-reviewed

Therapeutic effects of ibuprofen on transgenic mice models of neurodegenerative diseases

Kazunari Sekiyama, Masayo Fujita, Akio Sekigawa, Yoshiki Takamatsu, Makoto Hashimoto

Ibuprofen: Clinical Pharmacology, Medical Uses and Adverse Effects, 369-375, 2013

Papers

Menu

Coauthors